ABOUT SYROSINGOPINE

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely made TPD strategies. With this evaluate, we deal with each preclinical experiments and clinical trials to supply an extensive summary of the safety and clinical effectiveness of PROTACs and MGDs in hematologic malignancies in the last 20 years.